Prostate Caner
Conditions
Interventions
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
Male
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as mCRPC according to EAU-ESTRO-SIOG 2016 and PSA > 10ng/ml; 2. No previous treatment with novel hormonal therapy; 3. ECOG 0-2; 4. Normal organ function, WBC >= 3000/mm3 or Neutrophil >= 1500/mm3; 5. Aged 18 to 85 years old when issuing written informed consent; 6. Life expectancy > 12 months. 7. Consent and able to carry out follow-up visit and cooperate with all other study procedures.
Exclusion criteria
Exclusion criteria: 1. Severe disease or other medical conditions suggesting a high risk of death within 1 year, which may interfere with follow-up. Decided by investigator; 2. Diagnosed with any other malignant tumor within 3 years before enrollment; 3. Unable to provide necessary follow-up information; 4. Other conditions that are judged as ineligible by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lesion heterogeneity on dual-tracer PET/CT;genomic change; | — |
Countries
China
Contacts
Public ContactDingwei Ye, Yao Zhu
Fudan University Shanghai Cancer Center
Outcome results
None listed